Tag: pharmaceuticals
-
Diabetes Cell Therapy Biotech Acquired in $320M Deal
A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals.
-
AI Analytics Find New ALS Genetic Drug Targets
Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS.
-
Human Organoids Show Drug Activity in Lab Animals
A study shows implanted lab-grown pieces of human 3-D kidney tissue can demonstrate chemical activity of drugs in preclinical tests with lab rats.
-
Precision Microbial Resistance Joint Venture Formed
Biotech, pharma, and diagnostics companies are forming a new business to design precision diagnostics and treatments for drug-resistant microbes.
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.
-
FDA Issues Action Plan for Rare Neuro Diseases
The Food and Drug Administration published its blueprint to encourage new treatments for rare neurodegenerative disorders, including ALS.
-
Trial Underway of Nasal Spray Flu Vaccine
A clinical trial has begun testing an influenza vaccine given as a nasal spray with a conventional syringe-delivered vaccine among older U.S. adults.
-
Biotech in $1.5B Gene-Editing Tech License Deal
A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease.
-
Gene Therapy Start-Up Gains $38M in Early Funds
A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds.
-
Life Science Investors Raise $1.1B for New Fund
A venture capital company specializing in health and life sciences start-up enterprises is raising $1.1 billion for a new investment fund.